Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease
Por um escritor misterioso
Descrição
Histone Deacetylase Inhibitors as Therapeutic Agents for Acute
Design, Synthesis, and Blood–Brain Barrier Transport Study of
Biomolecules, Free Full-Text
The role of HDAC inhibitors in Alzheimer's disease. First, HDAC
Histone Deacetylase Inhibitors: Design, Synthesis, and Biological
Pharmaceuticals, Free Full-Text
Development of a Novel, Small-Molecule Brain-Penetrant Histone
Largazole is a Brain-Penetrant Class I HDAC Inhibitor with
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of
Discovery of Novel Tacrine–Pyrimidone Hybrids as Potent Dual AChE
Design, Synthesis, and Proof of Concept of Balanced Dual
